# FDA Inspection 664821 - SGS North America Inc. - May 27, 2010

Source: https://www.keypedia.com/records/fda_inspections/sgs-north-america-inc/eb5a3e8a-cd15-4749-a042-a4e3d8ea6583
Source feed: FDA_Inspections

> FDA Inspection 664821 for SGS North America Inc. on May 27, 2010. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 664821
- Company Name: SGS North America Inc.
- Inspection Date: 2010-05-27
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1308948 - 2026-03-20](https://www.keypedia.com/records/fda_inspections/sgs-north-america-inc/166202d5-13e0-4326-abab-a6277b1a2b56)
- [FDA Inspection 1308948 - 2026-03-20](https://www.keypedia.com/records/fda_inspections/sgs-north-america-inc/8d90b2b7-d7cd-44af-83c0-2f2c8c5e0215)
- [FDA Inspection 1297328 - 2025-09-18](https://www.keypedia.com/records/fda_inspections/sgs-north-america-inc/f0070983-4eef-438e-b24e-288b30e99fee)
- [FDA Inspection 1297328 - 2025-09-18](https://www.keypedia.com/records/fda_inspections/sgs-north-america-inc/c9f6bd31-b2bb-42d5-95a6-458f71051ce5)
- [FDA Inspection 1194448 - 2023-01-10](https://www.keypedia.com/records/fda_inspections/sgs-north-america-inc/9b9a1a03-ff8c-486c-a7b4-38376eee5aa2)

Company: https://www.keypedia.com/companies/sgs-north-america-inc/720655d2-660d-4355-81b5-bf1fb4da0a89

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c